These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 39081726

  • 1. Ex vivo C5b-9 Deposition Test to Monitor Complement Activity in Clinical and Subclinical Atypical Hemolytic Uremic Syndrome and in Transplantation-Associated Thrombotic Microangiopathy.
    Martin M, Llorens-Cebria C, León-Román J, Perurena-Prieto J, Perez-Beltran V, Saumell S, Torres IB, Agraz I, Sellarès J, Ramos N, Bestard O, López M, Moreso F, Ariceta G, Soler MJ, Hernandez-Gonzalez M, Jacobs-Cachá C.
    Kidney Int Rep; 2024 Jul; 9(7):2227-2239. PubMed ID: 39081726
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ex Vivo Test of Complement Dysregulation in Atypical Hemolytic Uremic Syndrome Kidney Transplant patients: A Pilot Study.
    Duineveld C, Bouwmeester RN, van den Heuvel LPWJ, van de Kar NCAJ, Wetzels JFM.
    Kidney Int Rep; 2024 Jan; 9(1):145-151. PubMed ID: 38312782
    [Abstract] [Full Text] [Related]

  • 4. Modeling complement activation on human glomerular microvascular endothelial cells.
    Stevens KH, Baas LM, van der Velden TJAM, Bouwmeester RN, van Dillen N, Dorresteijn EM, van Zuilen AD, Wetzels JFM, Michels MAHM, van de Kar NCAJ, van den Heuvel LP.
    Front Immunol; 2023 Jan; 14():1206409. PubMed ID: 37954621
    [Abstract] [Full Text] [Related]

  • 5. Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome-related factor H mutation.
    Ueda Y, Miwa T, Ito D, Kim H, Sato S, Gullipalli D, Zhou L, Golla M, Song D, Dunaief JL, Palmer MB, Song WC.
    Kidney Int; 2019 Jul; 96(1):67-79. PubMed ID: 30910380
    [Abstract] [Full Text] [Related]

  • 6. A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy.
    Che M, Moran SM, Smith RJ, Ren KYM, Smith GN, Shamseddin MK, Avila-Casado C, Garland JS.
    Kidney Int; 2024 May; 105(5):960-970. PubMed ID: 38408703
    [Abstract] [Full Text] [Related]

  • 7. Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation.
    Stea ED, Skerka C, Accetturo M, Pesce F, Wiech T, Hartman A, Pontrelli P, Conserva F, Castellano G, Zipfel PF, Gesualdo L.
    Front Immunol; 2022 May; 13():1008294. PubMed ID: 36451836
    [Abstract] [Full Text] [Related]

  • 8. An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome.
    Gastoldi S, Aiello S, Galbusera M, Breno M, Alberti M, Bresin E, Mele C, Piras R, Liguori L, Santarsiero D, Benigni A, Remuzzi G, Noris M.
    Front Immunol; 2023 May; 14():1112257. PubMed ID: 36845135
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series.
    Martins M, Bridoux F, Goujon JM, Meuleman MS, Ribes D, Rondeau E, Guerry MJ, Delmas Y, Levy B, Ducloux D, Kandel-Aznar C, Le Fur A, Garrouste C, Provot F, Gibier JB, Thervet E, Bruneval P, Rabant M, Karras A, Dragon Durey MA, Fremeaux-Bacchi V, Chauvet S.
    Am J Kidney Dis; 2022 Sep; 80(3):341-352. PubMed ID: 35217094
    [Abstract] [Full Text] [Related]

  • 12. Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP.
    Cataland SR, Holers VM, Geyer S, Yang S, Wu HM.
    Blood; 2014 Jun 12; 123(24):3733-8. PubMed ID: 24695849
    [Abstract] [Full Text] [Related]

  • 13. Thrombotic microangiopathy after kidney transplantation: Analysis of the Brazilian Atypical Hemolytic Uremic Syndrome cohort.
    Nga HS, Palma LMP, Ernandes Neto M, Fernandes-Charpiot IMM, Garcia VD, Kist R, Miranda SMC, Macedo de Souza PA, Pereira GM, de Andrade LGM.
    PLoS One; 2021 Jun 12; 16(11):e0258319. PubMed ID: 34748552
    [Abstract] [Full Text] [Related]

  • 14. Complement-Mediated Thrombotic Microangiopathy in Pregnancy: An Educational Case Report.
    Bruno V, Barth D, Jauhal A.
    Can J Kidney Health Dis; 2023 Jun 12; 10():20543581231209009. PubMed ID: 37942411
    [Abstract] [Full Text] [Related]

  • 15. Complement Activation and Thrombotic Microangiopathies.
    Palomo M, Blasco M, Molina P, Lozano M, Praga M, Torramade-Moix S, Martinez-Sanchez J, Cid J, Escolar G, Carreras E, Paules C, Crispi F, Quintana LF, Poch E, Rodas L, Goma E, Morelle J, Espinosa M, Morales E, Avila A, Cabello V, Ariceta G, Chocron S, Manrique J, Barros X, Martin N, Huerta A, Fraga-Rodriguez GM, Cao M, Martin M, Romera AM, Moreso F, Manonelles A, Gratacos E, Pereira A, Campistol JM, Diaz-Ricart M.
    Clin J Am Soc Nephrol; 2019 Dec 06; 14(12):1719-1732. PubMed ID: 31694864
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab.
    Cammett TJ, Garlo K, Millman EE, Rice K, Toste CM, Faas SJ.
    Mol Diagn Ther; 2023 Jan 06; 27(1):61-74. PubMed ID: 36329366
    [Abstract] [Full Text] [Related]

  • 18. Role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome.
    Magro CM, Momtahen S, Mulvey JJ, Yassin AH, Kaplan RB, Laurence JC.
    Am J Dermatopathol; 2015 May 06; 37(5):349-56; quiz 357-9. PubMed ID: 25893747
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis.
    Gäckler A, Schönermarck U, Dobronravov V, La Manna G, Denker A, Liu P, Vinogradova M, Yoon SS, Praga M.
    BMC Nephrol; 2021 Jan 06; 22(1):5. PubMed ID: 33407224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.